ESMO Clinical Practice Guideline Express Update on the management of metastatic pancreatic cancer
Cet article présente la mise à jour des recommandations de l'"European Society for Medical Oncology" concernant la prise en charge d'un cancer métastatique du pancréas
This ESMO Clinical Practice Guideline Express Update addresses developments in the management of metastatic pancreatic cancer.
It has been issued following the approval of first-line nanoliposomal irinotecan (NALIRIFOX regimen).
Updated first- and second-line treatment recommendations are provided.
An updated management algorithm for metastatic pancreatic cancer is also included.
ESMO Open , article en libre accès 2024